| D'arcy Adaire Honeycutt, MD | |
|
810 E Rosser Ave, Suite 303, Bismarck, ND 58501-4463 | |
| (701) 530-8450 | |
| (701) 530-8457 |
| Full Name | D'arcy Adaire Honeycutt |
|---|---|
| Gender | Female |
| Speciality | Surgery - Plastic And Reconstructive Surgery |
| Location | 810 E Rosser Ave, Bismarck, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184720948 | NPI | - | NPPES |
| 29333 | Other | KY | KY STATE MEDICAL LICENSE |
| H0460 | Other | TX | TX STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 7766 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| D'arcy Adaire Honeycutt, MD 810 E Rosser Ave, Suite 303, Bismarck, ND 58501-4463 Ph: (701) 530-8450 | D'arcy Adaire Honeycutt, MD 810 E Rosser Ave, Suite 303, Bismarck, ND 58501-4463 Ph: (701) 530-8450 |
News Archive
Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.
Two University of Houston faculty members have been named fellows of the National Academy of Inventors for their contributions to scientific and technological innovation.
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States.
In its ongoing series examining efforts to eradicate polio, NPR's "All Things Considered" aired a story on Wednesday looking at how health care workers in Pakistan are attempting to overcome challenges to immunizing the child population.
The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.
› Verified 4 days ago
Dr. Joshua John Knudson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5422 | |
Michael Brandon Huck, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-5383 | |
Dr. Steven K Hamar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 | |
Dr. William E Altringer, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 401 N 9th St, Bismarck, ND 58501 Phone: 701-530-6000 Fax: 701-530-6430 | |
Dr. George H Hilts Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 S 5th St, Bismarck, ND 58504 Phone: 701-222-3937 Fax: 701-222-8805 | |
Josephat Gichuhi Ngatia, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000 |